Plasma levels ofd-Dimer: a crosslinked fibrin-degradation product in female breast cancer

Authors:

Abstract
Plasma levels ofd-dimer, a degradation product of crosslinked fibrin, were determined in 73 patients with breast cancer. In these patients, significantly elevated plasma levels ofd-dimer were found, as compared to healthy controls (Pr=0.40;Pr=0.39;PPr= 0.25;P<0.05) was found. We conclude that the increase in plasmad-dimer and TAT levels might reflect an enhanced activation of the clotting system in patients with breast cancer.

This publication has 22 references indexed in Scilit: